ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction

NCT ID: NCT07111975

Last Updated: 2025-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

3800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ANEURYSM@RISK is an observational study aiming to develop and validate an artificial intelligence (AI)-based prediction model for the growth and rupture of intracranial aneurysms (IAs). By applying automated 3D segmentation and morphological quantification of IAs from MR angiography (MRA) scans, the model is intended to provide clinicians with objective and reproducible risk estimates of aneurysm instability.

The study utilizes retrospective imaging data from multiple European centers, including UMC Utrecht, AP-HP Paris, and University Medical Center Hamburg-Eppendorf (UKE). A clinical vignette study will evaluate the model's clinical utility and user experience among interventional radiologists.

This study is exempt from medical ethics review (non-WMO in the Netherlands), as it involves only existing, anonymized data and imposes no additional burden on patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ANEURYSM@RISK study is part of the SHERPA project (Smart Human-centred Effortless support for Professional clinical Applications). The study aims to develop and validate a multivariable artificial intelligence (AI)-based prediction model to identify unstable unruptured intracranial aneurysms (UIAs), using morphological and clinical features.

Retrospective MR angiography (MRA) data will be collected from three clinical sites: UMC Utrecht (The Netherlands), AP-HP Paris (France), and University Medical Center Hamburg-Eppendorf (Germany). The study workflow includes:

* Development of AI algorithms for 3D shape feature extraction after automated aneurysm segmentation
* Training of predictive models for aneurysm growth and rupture based on morphological and clinical parameters
* Validation of model performance using a longitudinal dataset of \~1,000 patients (target C-statistic ≥ 0.80)
* A clinical vignette study in real-life settings to evaluate usability, decision-making impact, and inter-clinician variability

Key Performance Indicators (KPIs):

* Discriminative performance for aneurysm instability prediction; C-statistic ≥ 0.80
* Sensitivity ≥ 80% and specificity ≥ 50% (based on optimal cut-off values)
* ≥ 25% reduction in time to clinical decision-making
* ≥ 80% adherence to AI-generated suggestions by interventional radiologists
* ≥ 20% improvement in user experience using 3D visualization compared to 2D displays (survey-based)
* ≥ 50% reduction in inter- and intra-observer variability in aneurysm assessment

Ethical Considerations:

This is a non-interventional, retrospective study using previously acquired and anonymized imaging data. No additional procedures or data collection will be performed. The study poses no added burden or risk to patients. According to Dutch regulations, it is not subject to the Medical Research Involving Human Subjects Act (non-WMO).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Aneurysms Unruptured Intracranial Aneurysm Subarachnoid Hemorrhage (SAH) From Ruptured Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stable Intracranial Aneurysm Group

Participants with unruptured intracranial aneurysms (UIAs) that remained stable over time, showing no morphological growth or rupture during follow-up. Data are sourced from UMC Utrecht, UKE Hamburg, and AP-HP Paris.

No interventions assigned to this group

Unstable Intracranial Aneurysm Group

Participants with intracranial aneurysms (IAs) that demonstrated instability over time, defined as morphological growth and/or rupture during follow-up. Data are sourced from UMC Utrecht, UKE Hamburg, and AP-HP Paris.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Available MR angiography (MRA) scans of the Circle of Willis
* Presence of at least one intracranial aneurysm (IA)
* Availability of follow-up imaging or clinical records indicating stability, growth, or rupture

Exclusion Criteria

* Imaging of insufficient quality for segmentation or analysis
* Lack of follow-up data
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AP-HP (Assistance Publique - Hôpitaux de Paris), FRANCE : Hôpital Pitié Salpêtrière, Hôpital Bichat

UNKNOWN

Sponsor Role collaborator

University Medical Center Hamburg-Eppendorf (UKE)

UNKNOWN

Sponsor Role collaborator

Philips Medical Systems

INDUSTRY

Sponsor Role collaborator

UMC Utrecht

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Phebe J Groenheide, MSc

PhD Candidate, Department of Radiology/Neurology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Medical Center (UMC) Utrecht

Utrecht, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Related Links

Access external resources that provide additional context or updates about the study.

https://doi.org/10.3030/101194744

SHERPA: Smart Human-centred Effortless support for Professional clinical Applications

https://sherpa-ihi.eu/

SHERPA: Smart Human-centred Effortless support for Professional clinical Applications

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23U-0036_AWARE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MRI Analysis in the Growth of Cerebral Aneurysms
NCT06705452 NOT_YET_RECRUITING NA